Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16501248)

  • 1. Genetic variants in epigenetic genes and breast cancer risk.
    Cebrian A; Pharoah PD; Ahmed S; Ropero S; Fraga MF; Smith PL; Conroy D; Luben R; Perkins B; Easton DF; Dunning AM; Esteller M; Ponder BA
    Carcinogenesis; 2006 Aug; 27(8):1661-9. PubMed ID: 16501248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tagging single-nucleotide polymorphisms in antioxidant defense enzymes and susceptibility to breast cancer.
    Cebrian A; Pharoah PD; Ahmed S; Smith PL; Luccarini C; Luben R; Redman K; Munday H; Easton DF; Dunning AM; Ponder BA
    Cancer Res; 2006 Jan; 66(2):1225-33. PubMed ID: 16424062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ERCC4 associated with breast cancer risk: a two-stage case-control study using high-throughput genotyping.
    Milne RL; Ribas G; González-Neira A; Fagerholm R; Salas A; González E; Dopazo J; Nevanlinna H; Robledo M; Benítez J
    Cancer Res; 2006 Oct; 66(19):9420-7. PubMed ID: 17018596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large-scale evaluation of genetic variants in candidate genes for colorectal cancer risk in the Nurses' Health Study and the Health Professionals' Follow-up Study.
    Hazra A; Chanock S; Giovannucci E; Cox DG; Niu T; Fuchs C; Willett WC; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):311-9. PubMed ID: 18268114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variation in TP53 and risk of breast cancer in a population-based case control study.
    Sprague BL; Trentham-Dietz A; Garcia-Closas M; Newcomb PA; Titus-Ernstoff L; Hampton JM; Chanock SJ; Haines JL; Egan KM
    Carcinogenesis; 2007 Aug; 28(8):1680-6. PubMed ID: 17449902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common genetic variation at PTEN and risk of sporadic breast and prostate cancer.
    Haiman CA; Stram DO; Cheng I; Giorgi EE; Pooler L; Penney K; Le Marchand L; Henderson BE; Freedman ML
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):1021-5. PubMed ID: 16702386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentially functional single nucleotide polymorphisms in the core nucleotide excision repair genes and risk of squamous cell carcinoma of the head and neck.
    An J; Liu Z; Hu Z; Li G; Wang LE; Sturgis EM; El-Naggar AK; Spitz MR; Wei Q
    Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1633-8. PubMed ID: 17684138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplex genotyping of 1107 SNPs from 232 candidate genes identified an association between IL1A polymorphism and breast cancer risk.
    Han W; Kang SY; Kang D; Park SK; Lee JY; Kim H; Park AK; Noh DY
    Oncol Rep; 2010 Mar; 23(3):763-9. PubMed ID: 20127018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
    BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common variants in RB1 gene and risk of invasive ovarian cancer.
    Song H; Ramus SJ; Shadforth D; Quaye L; Kjaer SK; Dicioccio RA; Dunning AM; Hogdall E; Hogdall C; Whittemore AS; McGuire V; Lesueur F; Easton DF; Jacobs IJ; Ponder BA; Gayther SA; Pharoah PD
    Cancer Res; 2006 Oct; 66(20):10220-6. PubMed ID: 17047088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
    Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
    Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDR1 C3435T polymorphism in patients with breast cancer.
    Turgut S; Yaren A; Kursunluoglu R; Turgut G
    Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic association of the human homologue of the mouse modifier Ptprj with breast cancer.
    Lesueur F; Pharoah PD; Laing S; Ahmed S; Jordan C; Smith PL; Luben R; Wareham NJ; Easton DF; Dunning AM; Ponder BA
    Hum Mol Genet; 2005 Aug; 14(16):2349-56. PubMed ID: 16000320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating new candidate SNPs as low penetrance risk factors in sporadic breast cancer: a two-stage Spanish case-control study.
    Vega A; Salas A; Milne RL; Carracedo B; Ribas G; Ruibal A; de León AC; González-Hernández A; Benítez J; Carracedo A
    Gynecol Oncol; 2009 Jan; 112(1):210-4. PubMed ID: 18950845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABCB1 and GST polymorphisms associated with TP53 status in breast cancer.
    Nordgard SH; Ritchie MD; Jensrud SD; Motsinger AA; Alnaes GI; Lemmon G; Berg M; Geisler S; Moore JH; Lønning PE; Børresen-Dale AL; Kristensen VN
    Pharmacogenet Genomics; 2007 Feb; 17(2):127-36. PubMed ID: 17301692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for XRCC4 in age at diagnosis and breast cancer risk.
    Allen-Brady K; Cannon-Albright LA; Neuhausen SL; Camp NJ
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1306-10. PubMed ID: 16835328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms in the DNA repair genes XRCC1, XRCC2 and XRCC3 and risk of breast cancer in Cyprus.
    Loizidou MA; Michael T; Neuhausen SL; Newbold RF; Marcou Y; Kakouri E; Daniel M; Papadopoulos P; Malas S; Kyriacou K; Hadjisavvas A
    Breast Cancer Res Treat; 2008 Dec; 112(3):575-9. PubMed ID: 18188695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endostatin gene variation and protein levels in breast cancer susceptibility and severity.
    Balasubramanian SP; Cross SS; Globe J; Cox A; Brown NJ; Reed MW
    BMC Cancer; 2007 Jun; 7():107. PubMed ID: 17587451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in folate metabolizing enzymes and transport proteins and the risk of breast cancer.
    Kotsopoulos J; Zhang WW; Zhang S; McCready D; Trudeau M; Zhang P; Sun P; Narod SA
    Breast Cancer Res Treat; 2008 Dec; 112(3):585-93. PubMed ID: 18204969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variation in the major mitotic checkpoint genes does not affect familial breast cancer risk.
    Vaclavicek A; Bermejo JL; Wappenschmidt B; Meindl A; Sutter C; Schmutzler RK; Kiechle M; Bugert P; Burwinkel B; Bartram CR; Hemminki K; Försti A
    Breast Cancer Res Treat; 2007 Dec; 106(2):205-13. PubMed ID: 17268814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.